|
Results of the Epiderm™ skin model study |
|||||
| Test Materials |
Exposure time (mins.) |
Mean OD540 |
% Viability |
ET50 mins. |
MIP |
|
|
|||||
| NEGATIVE CONTROL |
960 |
1.685 |
100 |
||
| 1440 |
|||||
| NANO-CeO2 |
960 |
2.010 |
119.29 |
1517.18 |
<0.01 |
| 1200 |
1.138 |
67.54 |
|||
| 1440 |
1.089 |
64.63 |
|||
| NON-NANO CeO2 |
960 |
1.994 |
92.87 |
> 1440 |
0.03 |
| 1200 |
1.975 |
97.36 |
|||
| 1440 |
1.729 |
85.23 |
|||
| POSITIVE CONTROL 1% TX100 |
240 |
1.035 |
61.42 |
260.10 |
<0.18 |
| 360 |
0.212 |
12.58 |
|||
| 480 |
0.095 |
5.64 |
|||
| REFERENCE MATERIAL 20% SLS |
15 |
0.983 |
58.34 |
20.68 |
1.00 |
| 30 |
0.710 |
42.14 |
|||
| 60 |
0.273 |
16.20 |
|||
| 120 |
0.100 |
5.93 |
|||
Park et al. Particle and Fibre Toxicology 2007 4:12 doi:10.1186/1743-8977-4-12 |
|||||